MTSS1 and breast carcinoma: Our data agrees with a previous report showing that miR-182 directly targets MIM (Missing in Metastasis), which suppresses metastasis by inhibiting Ras homolog family member A (RhoA) activity and stress fiber formation in breast cancer cells (Lei et al., 2014).